Earnings Feed
Start Free
Home/Filings/4/0001209191-03-021668
4//SEC Filing

LEVY RALPH E 4

Accession 0001209191-03-021668

CIK 0000913610other
View on SEC.govCompany Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 7:13 PM ET

Size

20.5 KB

Accession

0001209191-03-021668

Insider Transaction Report

Form 4
Period: 2003-09-11
SANGSTAT MEDICAL CORPSANG
LEVY RALPH E
SVP Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2003-09-11$12.99/sh+3,019$39,217→ 3,019 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−6,250$140,625→ 0 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−24,790$557,775→ 0 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$19.38/sh+2,299$44,555→ 2,299 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−10,210$229,725→ 0 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$10.75/sh+6,250$67,188→ 6,250 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$10.20/sh+8,022$81,849→ 8,022 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−2,299$51,728→ 0 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$10.20/sh+16,978$173,228→ 16,978 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$19.38/sh+25,701$498,085→ 25,701 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$8.07/sh+24,790$200,055→ 24,790 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−8,022$180,495→ 0 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−16,978$382,005→ 0 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−10,481$235,823→ 0 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−25,701$578,273→ 0 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$12.99/sh+10,481$136,148→ 10,481 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh−3,019$67,928→ 0 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$8.07/sh+10,210$82,395→ 10,210 total
Footnotes (1)
  • [F1]Option vesting was accelerated and the resulting common stock from the exercise and all outstanding common stock was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.

Documents

1 file

Issuer

SANGSTAT MEDICAL CORP

CIK 0000913610

→
Entity typeother

Related Parties

1
  • filerCIK 0001221592

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 7:13 PM ET
Size
20.5 KB
View on SEC.gov